2016.Jun.27

OBI Pharma 's 2016 Annual General Meeting has approved to release the newly elected Director from non-competition restriction

1.Date of the shareholders’ meeting resolution:2016/06/27 2.Name and title of the director with permission to engage in competitive conduct: Director  Michael Chang (Representative of Yi Tai Fund Co.) Director  Tamon Tseng (Representative of Yi Tai Fund Co.) Director  Lung-Yeh Cho (Representative of Sun Cheng Fund Co.) Director  Frank Chen (Representative of Sun Cheng Fund Co.) […]

HOMEWhat’s NewAnnouncementsOBI Pharma ‘s 2016 Annual General Meeting has approved to release the newly elected Director from non-competition restriction

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2016.Jun.27

OBI Pharma, Inc. announces the re-appointment of Mr. Michael Chang as the Chairman of the Company.

2016.Jun.27

The Re-election of Directors at 2016 Annual General Shareholders' Meeting